Advertisement
Medical Transparency: The Turkish Case
Medical Transparency: The Turkish Case
Medical Transparency: The Turkish Case
Medical Transparency: The Turkish Case
Medical Transparency: The Turkish Case
Medical Transparency: The Turkish Case
Medical Transparency: The Turkish Case

Check these out next

The Single-Payer Tornado
The Single-Payer Tornado
Kelley M. Bendele
Telemedicine: Challenges and Opportunities
Telemedicine: Challenges and Opportunities
David Harlow
Accessibility of medical marijuana
Accessibility of medical marijuana
JonathanJuca
Health Care Reform Developments Week of August 11, 2014[1]
Health Care Reform Developments Week of August 11, 2014[1]
Annette Wright, GBA, GBDS
Global anaesthesia & respiratory device markets
Global anaesthesia & respiratory device markets
renu91
Sociology Of Medicine
Sociology Of Medicine
reportgal30i
WHO Contribution to impementing MeTA
WHO Contribution to impementing MeTA
MeTApresents
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugs
ComplianceOnline
1 of 7

Medical Transparency: The Turkish Case

Sep. 17, 2009••
Download to read offline
Health & Medicine
Business

Presentation by Şerif BOYACI, pharmacist, Turkish Pharmacists' Association on Medical Transparency: The Turkish Case, during the 69th FIP Congress, Istanbul, September 2009.

MeTApresents
Communication & Capacity Strengthening Director
Advertisement
Advertisement
Advertisement

Recommended

Medicines Transparency KyrgyzstanMedicines Transparency Kyrgyzstan
Medicines Transparency KyrgyzstanMeTApresents559 views•10 slides
Abstract Report OncologyAbstract Report Oncology
Abstract Report OncologyNicola_C_Salerno268 views•1 slide
In vitro diagnostics to 2016In vitro diagnostics to 2016
In vitro diagnostics to 2016benturner0664 views•2 slides
TMB pain management rulesTMB pain management rules
TMB pain management rulesTexas Medical Liability Trust645 views•16 slides
Remote patient monitoring devices market is estimated to increase to us$ 1,50...Remote patient monitoring devices market is estimated to increase to us$ 1,50...
Remote patient monitoring devices market is estimated to increase to us$ 1,50...Rakesh Zanje56 views•10 slides
Justice Department Recovers OverJustice Department Recovers Over
Justice Department Recovers OverFrancisco Rivas79 views•3 slides

More Related Content

Slideshows for you(15)

The Single-Payer TornadoThe Single-Payer Tornado
The Single-Payer Tornado
Kelley M. Bendele•62 views
Telemedicine: Challenges and OpportunitiesTelemedicine: Challenges and Opportunities
Telemedicine: Challenges and Opportunities
David Harlow•1.8K views
Accessibility of medical marijuanaAccessibility of medical marijuana
Accessibility of medical marijuana
JonathanJuca•36 views
Health Care Reform Developments Week of August 11, 2014[1]Health Care Reform Developments Week of August 11, 2014[1]
Health Care Reform Developments Week of August 11, 2014[1]
Annette Wright, GBA, GBDS•132 views
Global anaesthesia & respiratory device marketsGlobal anaesthesia & respiratory device markets
Global anaesthesia & respiratory device markets
renu91•146 views
Sociology Of MedicineSociology Of Medicine
Sociology Of Medicine
reportgal30i•39 views
WHO Contribution to impementing MeTAWHO Contribution to impementing MeTA
WHO Contribution to impementing MeTA
MeTApresents•462 views
Fda adverse event reporting requirements for otc drugsFda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugs
ComplianceOnline•154 views
113931016 hhs-affordable-care-act113931016 hhs-affordable-care-act
113931016 hhs-affordable-care-act
homeworkping10•43 views
Soft tissue defect marketSoft tissue defect market
Soft tissue defect market
DelveInsight Business Research•8 views
2015 Lobby Day Official Policy Statement FINAL VERSION2015 Lobby Day Official Policy Statement FINAL VERSION
2015 Lobby Day Official Policy Statement FINAL VERSION
David Kim•135 views
Payers' SeminarPayers' Seminar
Payers' Seminar
Pinky Fadullon•202 views
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
Epstein Becker Green•570 views
The European Marijuana Business News ReportThe European Marijuana Business News Report
The European Marijuana Business News Report
Cannabis News•130 views
Summary of 2020 MPFS Final RuleSummary of 2020 MPFS Final Rule
Summary of 2020 MPFS Final Rule
MiraMed: A Global Services Company•29 views

Similar to Medical Transparency: The Turkish Case(20)

Health systems around the world - Memoona ArshadHealth systems around the world - Memoona Arshad
Health systems around the world - Memoona Arshad
Huzaifa Zahoor•37 views
Increasing access to medicinesIncreasing access to medicines
Increasing access to medicines
MeTApresents•1.5K views
Investigation of the accessibility and affordability of medicines in speciali...Investigation of the accessibility and affordability of medicines in speciali...
Investigation of the accessibility and affordability of medicines in speciali...
Cornelis Jan Diepeveen•99 views
Read Logica’s paper on the need for convergence of healthcare and pharmaRead Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharma
CGI•829 views
Value-based healthcare in France: A slow adoption of cost-effectiveness criteriaValue-based healthcare in France: A slow adoption of cost-effectiveness criteria
Value-based healthcare in France: A slow adoption of cost-effectiveness criteria
The Economist Media Businesses•766 views
IMS - Global Use of Medicines 2020 by Nitesh BheleIMS - Global Use of Medicines 2020 by Nitesh Bhele
IMS - Global Use of Medicines 2020 by Nitesh Bhele
Nitesh Bhele•1.7K views
The Orphan Drug ActThe Orphan Drug Act
The Orphan Drug Act
biotechpro•2.1K views
Quo Vadis EU Pharmacy?Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?
inemet•1.8K views
Iihi us use_of_meds_for_2013Iihi us use_of_meds_for_2013
Iihi us use_of_meds_for_2013
Georgi Daskalov•1.1K views
Universal heath coverage_muskan_guptaUniversal heath coverage_muskan_gupta
Universal heath coverage_muskan_gupta
MuskanGupta85•52 views
Prescription Medicines Costs in Context - June 2019Prescription Medicines Costs in Context - June 2019
Prescription Medicines Costs in Context - June 2019
PhRMA•6.5K views
Prescription Medicines Costs in Context January 2020Prescription Medicines Costs in Context January 2020
Prescription Medicines Costs in Context January 2020
PhRMA•2.5K views
Value-based healthcare in PortugalValue-based healthcare in Portugal
Value-based healthcare in Portugal
The Economist Media Businesses•1K views
MSD AIA Forum - 2009 BrochureMSD AIA Forum - 2009 Brochure
MSD AIA Forum - 2009 Brochure
Boris Azaïs•111 views
Applying human rights to advocacy campaigns for access to essential medicines...Applying human rights to advocacy campaigns for access to essential medicines...
Applying human rights to advocacy campaigns for access to essential medicines...
MeTApresents•863 views
Prescription Medicines - Costs in Context January 2019Prescription Medicines - Costs in Context January 2019
Prescription Medicines - Costs in Context January 2019
PhRMA•2.4K views
Prescription Medicines - Costs In Context March 2019Prescription Medicines - Costs In Context March 2019
Prescription Medicines - Costs In Context March 2019
PhRMA•6K views
The Value of Integrated CareThe Value of Integrated Care
The Value of Integrated Care
Andrea MANTOVANI•3K views
2013 Romanian legal framework of medically assisted reproduction2013 Romanian legal framework of medically assisted reproduction
2013 Romanian legal framework of medically assisted reproduction
Asociatia SOS Infertilitatea - www.vremcopii.ro•1.8K views
Presentatie Leers Augustus 2007 Tbv Chinese Delegation JppcPresentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
Presentatie Leers Augustus 2007 Tbv Chinese Delegation Jppc
marusjkalestrade•393 views
Advertisement

More from MeTApresents(20)

MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
MeTApresents•815 views
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
MeTApresents•1.2K views
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
MeTApresents•1.1K views
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
MeTApresents•1.1K views
MeTA introductionMeTA introduction
MeTA introduction
MeTApresents•750 views
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
MeTApresents•697 views
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
MeTApresents•800 views
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
MeTApresents•892 views
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
MeTApresents•919 views
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
MeTApresents•848 views
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
MeTApresents•1.5K views
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
MeTApresents•564 views
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
MeTApresents•1K views
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
MeTApresents•837 views
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
MeTApresents•868 views
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
MeTApresents•512 views
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
MeTApresents•781 views
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
MeTApresents•361 views
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
MeTApresents•672 views
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
MeTApresents•1.5K views

Recently uploaded(20)

The Role of Photodynamic Therapy (PDT) in Treating Early Esophageal Cancer: T...The Role of Photodynamic Therapy (PDT) in Treating Early Esophageal Cancer: T...
The Role of Photodynamic Therapy (PDT) in Treating Early Esophageal Cancer: T...
semualkaira•0 views
ANTI-TOBACCO DAY.docxANTI-TOBACCO DAY.docx
ANTI-TOBACCO DAY.docx
RUDRAPRAKASHDAS•0 views
The DNA Damage Repair ResponseThe DNA Damage Repair Response
The DNA Damage Repair Response
semualkaira•0 views
Eligibility for ACOSOG Z0011 Trial and Results on a Cohort of 3546 Breast Can...Eligibility for ACOSOG Z0011 Trial and Results on a Cohort of 3546 Breast Can...
Eligibility for ACOSOG Z0011 Trial and Results on a Cohort of 3546 Breast Can...
semualkaira•0 views
MOTILITYMOTILITY
MOTILITY
VaisHali822687•0 views
The Hand-Held ThunderstormThe Hand-Held Thunderstorm
The Hand-Held Thunderstorm
semualkaira•0 views
CeAD.pptxCeAD.pptx
CeAD.pptx
DrMudasirMushtaq•0 views
Cubic Medical and Healthcare Gas Sensor SolutionCubic Medical and Healthcare Gas Sensor Solution
Cubic Medical and Healthcare Gas Sensor Solution
Cubic Sensor and Instrument Co., Ltd.•0 views
Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent...Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent...
Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent...
semualkaira•0 views
CONCEPT OF CONTROLLED –UNCONTROLLED DOCUMENTS & CTD.pdfCONCEPT OF CONTROLLED –UNCONTROLLED DOCUMENTS & CTD.pdf
CONCEPT OF CONTROLLED –UNCONTROLLED DOCUMENTS & CTD.pdf
Shankar Maind Patil •0 views
Jugular Venous Pressure jvp.pptxJugular Venous Pressure jvp.pptx
Jugular Venous Pressure jvp.pptx
desktoppc•0 views
ISO 14001 2004 GUIDE LINES.pdfISO 14001 2004 GUIDE LINES.pdf
ISO 14001 2004 GUIDE LINES.pdf
Shankar Maind Patil •0 views
HEALTH.pptxHEALTH.pptx
HEALTH.pptx
ssuserc8422b•0 views
LLMs in Healthcare and Pharma. VTI dayLLMs in Healthcare and Pharma. VTI day
LLMs in Healthcare and Pharma. VTI day
GeorgiosPapadakis17•0 views
thyroid disease 3.pptxthyroid disease 3.pptx
thyroid disease 3.pptx
AbdillahiOsmanMohamo•0 views
Radiation Induced Valvular Heart Disease: A Case Report and Review of the Lit...Radiation Induced Valvular Heart Disease: A Case Report and Review of the Lit...
Radiation Induced Valvular Heart Disease: A Case Report and Review of the Lit...
semualkaira•0 views
HTN 23.pptxHTN 23.pptx
HTN 23.pptx
desktoppc•0 views
Bacterial structure.pptxBacterial structure.pptx
Bacterial structure.pptx
ShahriarHabib4•0 views
BLOOD_DISORDERS-2[1].pptxBLOOD_DISORDERS-2[1].pptx
BLOOD_DISORDERS-2[1].pptx
Ezekielkariuki1•0 views
13_Respiratory_distress_16-Sep-09[1].ppt13_Respiratory_distress_16-Sep-09[1].ppt
13_Respiratory_distress_16-Sep-09[1].ppt
Ezekielkariuki1•0 views
Advertisement

Medical Transparency: The Turkish Case

  1. Medical Transparency: The Turkish Case Şerif BOYACI, pharmacist Turkish Pharmacists' Association
Advertisement